Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 11, Number 6—June 2005

Research

Community Prescribing and Resistant Streptococcus pneumoniae

Galia Barkai*, David Greenberg*, Noga Givon-Lavi*, Eli Dreifuss†, Daniel Vardy†, and Ron Dagan*Comments to Author 
Author affiliations: *Soroka University Medical Center and Ben-Gurion University of the Negev, Beer-Sheva, Israel; †Israel General Health Insurance Plan, Beer-Sheva, Israel

Main Article

Figure 3

Proportions of erythromycin-resistant and multidrug-resistant Streptococcus pneumoniae isolated during episodes of acute otitis media in Bedouin and Jewish children <5 years of age in southern Israel from 1999 through 2003. Ery-R, erythromycin resistance; MDR, multidrug resistance (resistance to ≥3 antimicrobial classes).

Figure 3. . Proportions of erythromycin-resistant and multidrug-resistant Streptococcus pneumoniae isolated during episodes of acute otitis media in Bedouin and Jewish children <5 years of age in southern Israel from 1999 through 2003. Ery-R, erythromycin resistance; MDR, multidrug resistance (resistance to ≥3 antimicrobial classes).

Main Article

TOP